Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1374694-31-1

C81H106N6O38 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1374694-31-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1374694-31-1 Structure

  • Basic information

    1. Product Name: C81H106N6O38
    2. Synonyms:
    3. CAS NO:1374694-31-1
    4. Molecular Formula:
    5. Molecular Weight: 1771.75
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1374694-31-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C81H106N6O38(CAS DataBase Reference)
    10. NIST Chemistry Reference: C81H106N6O38(1374694-31-1)
    11. EPA Substance Registry System: C81H106N6O38(1374694-31-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1374694-31-1(Hazardous Substances Data)

1374694-31-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1374694-31-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,4,6,9 and 4 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1374694-31:
(9*1)+(8*3)+(7*7)+(6*4)+(5*6)+(4*9)+(3*4)+(2*3)+(1*1)=191
191 % 10 = 1
So 1374694-31-1 is a valid CAS Registry Number.

1374694-31-1Downstream Products

1374694-31-1Relevant articles and documents

Synthesis and antitumor efficacy of a β-glucuronidase-responsive albumin-binding prodrug of doxorubicin

Legigan, Thibaut,Clarhaut, Jonathan,Renoux, Brigitte,Tranoy-Opalinski, Isabelle,Monvoisin, Arnaud,Berjeaud, Jean-Marc,Guilhot, Fran?ois,Papot, Sébastien

, p. 4516 - 4520 (2012)

In this paper we describe the synthesis and biological evaluation of the first β-glucuronidase-responsive albumin-binding prodrug designed for the selective delivery of doxorubicin at the tumor site. This prodrug leads to superior antitumor efficacy in mice compared to HMR 1826, a well-known glucuronide prodrug of doxorubicin that cannot bind covalently to circulating albumin. Furthermore, this compound inhibits tumor growth in a manner similar to that of doxorubicin while avoiding side effects induced by the free drug.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1374694-31-1